Semiflexible Immunobrushes Induce Enhanced T Cell Activation and Expansion.


Journal

ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991

Informations de publication

Date de publication:
14 Apr 2021
Historique:
pubmed: 3 4 2021
medline: 11 8 2021
entrez: 2 4 2021
Statut: ppublish

Résumé

A variety of bioactive materials developed to expand T cells for adoptive transfer into cancer patients are currently evaluated in the clinic. In most cases, T cell activating biomolecules are attached to rigid surfaces or matrices and form a static interface between materials and the signaling receptors on the T cells. We hypothesized that a T cell activating polymer brush interface might better mimic the cell surface of a natural antigen-presenting cell, facilitating receptor movement and concomitant advantageous mechanical forces to provide enhanced T cell activating capacities. Here, as a proof of concept, we synthesized semiflexible polyisocyanopeptide (PIC) polymer-based immunobrushes equipped with T cell activating agonistic anti-CD3 (αCD3) and αCD28 antibodies placed on magnetic microbeads. We demonstrated enhanced efficiency of

Identifiants

pubmed: 33797875
doi: 10.1021/acsami.0c21994
pmc: PMC8045021
doi:

Substances chimiques

Biocompatible Materials 0
Peptides 0
Polyurethanes 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

16007-16018

Références

Immunity. 2013 Nov 14;39(5):846-57
pubmed: 24120362
Nat Immunol. 2002 Nov;3(11):991-8
pubmed: 12407406
J Transl Med. 2005 Apr 28;3(1):17
pubmed: 15860133
Nat Rev Immunol. 2012 Mar 22;12(4):269-81
pubmed: 22437939
Curr Top Microbiol Immunol. 2010;340:81-107
pubmed: 19960310
J Biol Chem. 2011 Oct 7;286(40):34883-92
pubmed: 21849500
Cytotherapy. 2011 Aug;13(7):822-34
pubmed: 21428850
Small. 2015 Apr;11(13):1519-25
pubmed: 25641795
Biomacromolecules. 2019 Jul 8;20(7):2587-2597
pubmed: 31150222
Nano Lett. 2019 Oct 9;19(10):6945-6954
pubmed: 31478664
Int Immunopharmacol. 2013 Jan;15(1):129-37
pubmed: 23159335
Cancer Immunol Immunother. 2013 Oct;62(10):1563-73
pubmed: 23903715
ACS Omega. 2017 Mar 31;2(3):937-945
pubmed: 28393131
Bioconjug Chem. 2017 Oct 18;28(10):2560-2568
pubmed: 28846388
J Natl Cancer Inst. 1989 Nov 15;81(22):1709-17
pubmed: 2810387
Semin Immunol. 2009 Apr;21(2):69-77
pubmed: 19268606
Immunity. 2008 Oct 17;29(4):589-601
pubmed: 18848472
Nat Biotechnol. 2018 Feb;36(2):160-169
pubmed: 29334370
Immunol Rev. 2014 Jan;257(1):56-71
pubmed: 24329789
Annu Rev Immunol. 2009;27:591-619
pubmed: 19132916
Curr Opin Immunol. 2006 Jun;18(3):305-13
pubmed: 16616469
Top Curr Chem (Cham). 2016 Apr;374(2):16
pubmed: 27573141
J Clin Oncol. 2013 Jun 10;31(17):2152-9
pubmed: 23650429
Biomaterials. 2014 Jan;35(1):269-277
pubmed: 24099710
J Clin Oncol. 1989 Feb;7(2):250-61
pubmed: 2644399
Proc Natl Acad Sci U S A. 2019 Oct 1;116(40):19835-19840
pubmed: 31527238
Sci Transl Med. 2015 Mar 25;7(280):280ps7
pubmed: 25810311
Nano Lett. 2017 Nov 8;17(11):7045-7054
pubmed: 28994285
Immunol Rev. 2009 May;229(1):5-11
pubmed: 19426211
Biochim Biophys Acta. 2015 Apr;1853(4):781-90
pubmed: 25200637
J Transl Med. 2010 Oct 26;8:104
pubmed: 20977748
J Immunol. 2012 Aug 1;189(3):1330-9
pubmed: 22732590
Front Immunol. 2016 Sep 06;7:345
pubmed: 27656185
Immunology. 2011 Aug;133(4):420-5
pubmed: 21631496
Nano Lett. 2017 Feb 8;17(2):821-826
pubmed: 28122453
Expert Opin Biol Ther. 2006 Mar;6(3):215-29
pubmed: 16503732
J Immunol. 1992 Oct 1;149(7):2402-5
pubmed: 1527386
Cancer Immunol Immunother. 2014 Oct;63(10):1081-91
pubmed: 25099366
Trends Immunol. 2015 Apr;36(4):265-76
pubmed: 25797516
Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):E5454-63
pubmed: 27573839
J Clin Invest. 2007 May;117(5):1204-12
pubmed: 17476350
Trends Biotechnol. 2014 Sep;32(9):456-65
pubmed: 24998519
Blood. 2014 Jun 12;123(24):3750-9
pubmed: 24782509
Nat Nanotechnol. 2014 Aug;9(8):639-47
pubmed: 25086604
J Immunother. 2004 Sep-Oct;27(5):405-18
pubmed: 15314550
Clin Transl Immunology. 2015 Jan 16;4(1):e31
pubmed: 25671129
Front Immunol. 2016 Jun 28;7:255
pubmed: 27446085
J Immunol Methods. 2003 Apr 1;275(1-2):251-5
pubmed: 12667688
Eur J Immunol. 2013 Nov;43(11):2797-809
pubmed: 24258910
Elife. 2017 Jun 08;6:
pubmed: 28594327
Immunol Cell Biol. 2017 Apr;95(4):356-363
pubmed: 28003642
Clin Cancer Res. 2011 Jul 1;17(13):4550-7
pubmed: 21498393
Nat Rev Immunol. 2015 Aug;15(8):486-99
pubmed: 26205583
Cold Spring Harb Perspect Biol. 2015 Jun 01;7(6):
pubmed: 26032717
J Immunol Res Ther. 2017;2(1):68-79
pubmed: 28825053
J Immunol Methods. 2010 Apr 15;355(1-2):52-60
pubmed: 20171968
Nano Lett. 2013;13(11):5608-14
pubmed: 24125583
Mol Ther Methods Clin Dev. 2017 Nov 07;8:65-74
pubmed: 29687031
Semin Immunol. 2016 Feb;28(1):28-34
pubmed: 26976826
Cancer Immunol Res. 2014 Nov;2(11):1023-33
pubmed: 25367977
Adv Immunol. 2006;90:51-81
pubmed: 16730261
ACS Chem Biol. 2015 Feb 20;10(2):485-92
pubmed: 25372624
Mol Ther. 2008 Apr;16(4):765-72
pubmed: 18334990
J Clin Oncol. 2015 May 10;33(14):1543-50
pubmed: 25823737
Nano Lett. 2013 Nov 13;13(11):5090-7
pubmed: 24111628

Auteurs

Roel Hammink (R)

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands.
Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, Netherlands.

Jorieke Weiden (J)

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands.
Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, Netherlands.
Institute for Chemical Immunology, 6525 GA Nijmegen, Netherlands.

Dion Voerman (D)

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands.
Institute for Chemical Immunology, 6525 GA Nijmegen, Netherlands.

Carlijn Popelier (C)

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands.

Loek J Eggermont (LJ)

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands.
Institute for Chemical Immunology, 6525 GA Nijmegen, Netherlands.

Marjolein Schluck (M)

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands.
Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, Netherlands.
Institute for Chemical Immunology, 6525 GA Nijmegen, Netherlands.

Carl G Figdor (CG)

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands.
Division of Immunotherapy, Oncode Institute, Radboud University Medical Center, 6525 GA Nijmegen, Netherlands.
Institute for Chemical Immunology, 6525 GA Nijmegen, Netherlands.

Martijn Verdoes (M)

Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Geert Grooteplein 26, 6525 GA Nijmegen, Netherlands.
Institute for Chemical Immunology, 6525 GA Nijmegen, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH